Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 09, 2022

BUY
$28.82 - $77.35 $34,584 - $92,820
1,200 New
1,200 $48,000
Q1 2022

May 16, 2022

SELL
$48.25 - $100.49 $161,106 - $335,536
-3,339 Closed
0 $0
Q4 2021

Feb 11, 2022

SELL
$88.71 - $120.43 $175,645 - $238,451
-1,980 Reduced 37.23%
3,339 $334,000
Q3 2021

Nov 16, 2021

SELL
$98.77 - $132.17 $96,201 - $128,733
-974 Reduced 15.48%
5,319 $665,000
Q2 2021

Aug 12, 2021

SELL
$109.77 - $165.68 $38,309 - $57,822
-349 Reduced 5.25%
6,293 $782,000
Q1 2021

May 17, 2021

SELL
$127.04 - $179.1 $175,061 - $246,799
-1,378 Reduced 17.18%
6,642 $1.01 Million
Q4 2020

Feb 09, 2021

SELL
$99.96 - $135.93 $216,313 - $294,152
-2,164 Reduced 21.25%
8,020 $1.03 Million
Q3 2020

Nov 12, 2020

SELL
$80.32 - $111.8 $379,672 - $528,478
-4,727 Reduced 31.7%
10,184 $1.14 Million
Q2 2020

Jul 27, 2020

SELL
$60.49 - $97.5 $99,385 - $160,192
-1,643 Reduced 9.93%
14,911 $1.21 Million
Q1 2020

May 13, 2020

BUY
$59.04 - $88.81 $353,472 - $531,705
5,987 Added 56.66%
16,554 $1.15 Million
Q4 2019

Jan 22, 2020

BUY
$59.49 - $82.78 $40,155 - $55,876
675 Added 6.82%
10,567 $826,000
Q3 2019

Oct 15, 2019

BUY
$62.59 - $110.3 $13,769 - $24,266
220 Added 2.27%
9,892 $631,000
Q2 2019

Jul 19, 2019

BUY
$63.94 - $91.11 $251,412 - $358,244
3,932 Added 68.5%
9,672 $835,000
Q1 2019

May 10, 2019

BUY
$34.3 - $97.98 $170,299 - $486,470
4,965 Added 640.65%
5,740 $440,000
Q4 2018

Feb 13, 2019

BUY
$29.2 - $46.1 $22,630 - $35,727
775 New
775 $29,000

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $4.48B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Sea Crest Wealth Management, LLC Portfolio

Follow Sea Crest Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sea Crest Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sea Crest Wealth Management, LLC with notifications on news.